Eventide Asset Management - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$53,884,014
+4.9%
575,438
+0.0%
0.97%
+11.5%
Q2 2023$51,357,395
-38.8%
575,432
-26.5%
0.87%
-43.6%
Q1 2023$83,936,105
-12.2%
782,840
+0.0%
1.54%
-18.3%
Q4 2022$95,592,250
-22.8%
782,709
-34.7%
1.88%
-22.6%
Q3 2022$123,809,000
+11.1%
1,199,0000.0%2.44%
+2.2%
Q2 2022$111,459,000
-28.6%
1,199,000
-9.8%
2.38%
-2.5%
Q1 2022$156,022,000
-33.7%
1,329,432
-24.0%
2.44%
-18.7%
Q4 2021$235,246,000
-15.6%
1,748,6480.0%3.01%
-18.2%
Q3 2021$278,717,000
+24.7%
1,748,648
+2.9%
3.68%
+22.4%
Q2 2021$223,457,000
+2.1%
1,698,6480.0%3.00%
-7.5%
Q1 2021$218,922,000
-23.0%
1,698,648
-0.3%
3.24%
-25.6%
Q4 2020$284,218,000
+7.7%
1,704,148
-0.3%
4.36%
-15.6%
Q3 2020$263,864,000
+4.3%
1,709,8480.0%5.16%
-6.0%
Q2 2020$252,887,000
+32.2%
1,709,848
+0.7%
5.50%
-11.3%
Q1 2020$191,285,000
-19.1%
1,698,6480.0%6.19%
-7.0%
Q4 2019$236,316,000
+44.4%
1,698,6480.0%6.66%
+23.2%
Q3 2019$163,614,000
-16.4%
1,698,6480.0%5.41%
-9.1%
Q2 2019$195,599,000
-2.2%
1,698,6480.0%5.95%
-13.6%
Q1 2019$199,931,000
+87.9%
1,698,6480.0%6.88%
+46.0%
Q4 2018$106,420,000
-2.8%
1,698,648
+10.0%
4.71%
+17.2%
Q3 2018$109,472,000
+18.7%
1,544,900
+11.4%
4.02%
+5.0%
Q2 2018$92,263,000
+5.9%
1,387,000
+4.1%
3.83%
-6.2%
Q1 2018$87,148,000
+63.3%
1,332,5400.0%4.08%
+46.6%
Q4 2017$53,382,000
+22.3%
1,332,540
+10.6%
2.78%
+12.4%
Q3 2017$43,665,000
+145.8%
1,204,540
+88.2%
2.48%
+123.8%
Q2 2017$17,766,000
+157.8%
640,000
+160.1%
1.11%
+142.5%
Q1 2017$6,891,000
+48.7%
246,100
+7.5%
0.46%
+51.0%
Q4 2016$4,635,000229,0000.30%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders